pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,934 catalysts · 3,590 8k filing · 1,353 grant · 1,000 device adverse event · 582 earnings · 581 approval · 457 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 17 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×from 2026-02-26×clear all
type
  • 8k filing3,590
  • grant1,353
  • device adverse event1,000
  • earnings582
  • approval581
  • device 510k457
device pma
278
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area

    no tagged catalysts yet

    Week of Feb 23, 2026

    50
    ›Feb 26, 2026approval184d agoXeomin (incobotulinumtoxinA) — FDA approvalMerz Pharmaceuticals LLC

    Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 26, 2026approval184d agoDAPSONE — FDA approvalDAPSONE

    Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

    full page →DAPSONE →fda approvals ↗
    ›Feb 26, 2026approval184d agoJASCAYD (NERANDOMILAST) — FDA approvalnerandomilast

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

    full page →nerandomilast →fda approvals ↗
    ›Feb 26, 2026approval184d agoVYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approvalARGENX SE

    Sponsor: ARGENX BV. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 26, 2026approval184d agoBUMETANIDE — FDA approvalEdenbridge Pharmaceuticals LLC

    Sponsor: ANTHEA PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 26, 2026approval184d agoPHYTONADIONE — FDA approvalPHYTONADIONE

    Sponsor: SINOTHERAPEUTICS INC. Form: TABLET. Route: ORAL

    full page →PHYTONADIONE →fda approvals ↗
    ›Feb 26, 2026approval184d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: TARO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 26, 2026approval184d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: TARO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 26, 2026approval184d agoHERNEXEOS (ZONGERTINIB) — FDA approvalzongertinib

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

    full page →zongertinib →fda approvals ↗
    ›Feb 26, 2026approval184d agoRIZAFILM (RIZATRIPTAN BENZOATE) — FDA approvalNAL Pharmaceuticals Ltd

    Sponsor: GENSCO. Form: FILM. Route: ORAL

    full page →fda approvals ↗
    ›Feb 26, 2026approval184d agoDALBAVANCIN HYDROCHLORIDE — FDA approvalLong Grove Pharmaceuticals LLC

    Sponsor: LONG GROVE PHARMS. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 26, 2026approval184d agoENSACOVE (ENSARTINIB HYDROCHLORIDE) — FDA approvalensartinib hydrochloride

    Sponsor: XCOVERY. Form: CAPSULE. Route: ORAL

    full page →ensartinib hydrochloride →fda approvals ↗
    ›Feb 26, 2026approval184d agoPHYTONADIONE — FDA approvalPHYTONADIONE

    Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION

    full page →PHYTONADIONE →fda approvals ↗
    ›Feb 26, 2026approval184d agoIVERMECTIN — FDA approvalIVERMECTIN

    Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

    full page →IVERMECTIN →fda approvals ↗
    ›Feb 26, 2026grant184d agoBETH ISRAEL DEACONESS MEDICAL CENTER — THWART-TB : Testing Health Workers At Risk to advance our understanding of TB...

    AI grant. $111,645. PI: Ruvandhi Nathavitharana

    full page →nih reporter ↗
    ›Feb 26, 2026grant184d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Uncovering Morphogenetic Modularity with Data Science

    GM grant. $400,881. PI: Tomer Stern

    full page →nih reporter ↗
    ›Feb 26, 2026grant184d agoUNIVERSITY OF CALIFORNIA AT DAVIS — Multi-glycomic characterization of cell membrane and the role of glycans in p...

    GM grant. $402,051. PI: CARLITO B LEBRILLA

    full page →nih reporter ↗
    ›Feb 27, 2026approval183d agoPREZCOBIX (DARUNAVIR AND COBICISTAT) — FDA approvalGILEAD SCIENCES, INC.

    Sponsor: JANSSEN PRODS. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 27, 2026approval183d agoDILTIAZEM HYDROCHLORIDE — FDA approvalDILTIAZEM HYDROCHLORIDE

    Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →DILTIAZEM HYDROCHLORIDE →fda approvals ↗
    ›Feb 27, 2026approval183d agoSILIQ (BRODALUMAB) — FDA approvalBausch Health US LLC

    Sponsor: VALEANT LUXEMBOURG. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 27, 2026approval183d agoZEPZELCA (LURBINECTEDIN) — FDA approvallurbinectedin

    Sponsor: JAZZ. Form: POWDER. Route: INTRAVENOUS

    full page →lurbinectedin →fda approvals ↗
    ›Feb 27, 2026approval183d agoPALYNZIQ (PEGVALIASE-PQPZ) — FDA approvalBIOMARIN PHARMACEUTICAL INC

    Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 27, 2026approval183d agoCALCITRIOL — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: HUMANWELL PURACAP. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 27, 2026approval183d agoPREZCOBIX (COBICISTAT) — FDA approvalGILEAD SCIENCES, INC.

    Sponsor: JANSSEN PRODS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 27, 2026approval183d agoDULOXETINE HYDROCHLORIDE — FDA approvalduloxetine hydrochloride DR

    Sponsor: ALMATICA. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →duloxetine hydrochloride DR →fda approvals ↗
    ›Feb 27, 2026approval183d agoIZERVAY (AVACINCAPTAD PEGOL SODIUM) — FDA approvalavacincaptad pegol sodium

    Sponsor: ASTELLAS. Form: SOLUTION. Route: INTRAVITREAL

    full page →avacincaptad pegol sodium →fda approvals ↗
    ›Feb 27, 2026approval183d agoREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalluspatercept

    Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS

    full page →luspatercept →fda approvals ↗
    ›Feb 27, 2026approval183d agoYUVIWEL (NAVEPEGRITIDE) — FDA approvalnavepegritide

    Sponsor: ASCENDIS. Form: POWDER. Route: SUBCUTANEOUS

    full page →navepegritide →fda approvals ↗
    ›Feb 27, 2026approval183d agoSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvaltedizolid phosphate

    Sponsor: CUBIST PHARMS LLC. Form: TABLET. Route: ORAL

    full page →tedizolid phosphate →fda approvals ↗
    ›Feb 27, 2026approval183d agoSOGROYA (SOMAPACITAN-BECO) — FDA approvalsomatriptan albumin bound LA

    Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →somatriptan albumin bound LA →fda approvals ↗
    ›Feb 27, 2026approval183d agoSOGROYA (SOMAPACITAN-BECO) — FDA approvalsomatriptan albumin bound LA

    Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →somatriptan albumin bound LA →fda approvals ↗
    ›Feb 27, 2026approval183d agoSOGROYA (SOMAPACITAN-BECO) — FDA approvalsomatriptan albumin bound LA

    Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →somatriptan albumin bound LA →fda approvals ↗
    ›Feb 27, 2026approval183d agoSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvaltedizolid phosphate

    Sponsor: CUBIST PHARMS LLC. Form: POWDER. Route: INTRAVENOUS

    full page →tedizolid phosphate →fda approvals ↗
    ›Feb 27, 2026approval183d agoDESMOPRESSIN ACETATE — FDA approvalFerring Pharmaceuticals Inc

    Sponsor: CAPLIN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 27, 2026grant183d agoUNIVERSITY OF KANSAS LAWRENCE — Antivirulence activity of skin microbiome-derived small molecules against Sta...Vincere Biosciences Inc

    GM grant. $205,995. PI: ROSANA BARRETO ROCHA FERREIRA

    full page →nih reporter ↗
    ›Feb 27, 2026grant183d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — A Scalable and Effective Digital Behavioral Intervention for Mitigating Hypog...

    DK grant. $780,220. PI: YU KUEI LIN

    full page →nih reporter ↗
    ›Feb 27, 2026grant183d agoDREXEL UNIVERSITY — Dopamine D1-like receptor stimulation promotes HIV neuroimmune pathogenesis i...

    DA grant. $50,196. PI: Yash Dinesh Agarwal

    full page →nih reporter ↗
    ›Feb 28, 2026grant182d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Investigating and targeting oxidative stress and ferroptosis in frontotempora...

    AG grant. $51,492. PI: Julie J. McInvale

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoGEORGE WASHINGTON UNIVERSITY — George Washington University-University of Sciences, Techniques and Technolog...

    TW grant. $124,785. PI: SEYDOU DOUMBIA

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Maternal Childhood Maltreatment-Influenced Prenatal Programming of Early Brai...

    HD grant. $249,000. PI: Vanessa Babineau

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoMODULO BIO, INC. — Developing an AI-Guided Triculture Platform to Model NeuroHIV specific Microg...

    MH grant. $1,479,470. PI: Steven A Schaffert

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoFLORIDA STATE UNIVERSITY — Healthy Choices to Reduce Stigma and Improve Self-Management of Alcohol and H...

    TW grant. $616,000. PI: Henna Budhwani

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoYALE UNIVERSITY — Coordination of germline chromatin organization mechanisms to initiate embryo...

    GM grant. $537,696. PI: VALERIE J REINKE

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoPENNSYLVANIA STATE UNIVERSITY, THE — Molecular Mechanisms of Chromatin Remodeling and Deacetylation

    GM grant. $425,667. PI: Jean-Paul Armache

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoSTANFORD UNIVERSITY — Myosin structure and function in health and diseaseStanford University

    GM grant. $494,796. PI: James Spudich

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoNORTH CAROLINA STATE UNIVERSITY RALEIGH — Integrating dynamic cell behaviors to drive cranial morphogenesis

    GM grant. $412,373. PI: Eric R Brooks

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoTEXAS A&M UNIVERSITY — Circadian Encoding of Reward-Seeking Behavior in the Mesolimbic Dopamine Pathway

    DA grant. $41,789. PI: Jordan Cook

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoPENNSYLVANIA STATE UNIV HERSHEY MED CTR — Therapeutic efficacy and mechanisms of psilocybin for traumatic stress-induce...COMPASS Pathways plc

    DA grant. $37,108. PI: Charles N Zawatsky

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoGORDON RESEARCH CONFERENCES — 2026 Neurobiology of Drug Addiction Gordon Research Conference and Gordon Res...

    DA grant. $9,880. PI: Nii A Addy

    full page →nih reporter ↗
    ›Mar 1, 2026grant181d agoJOHNS HOPKINS UNIVERSITY — Identifying and Measuring the Palliative Needs of Children in Foster CareJohns Hopkins University

    NR grant. $57,538. PI: Rebecca Singer Cohen

    full page →nih reporter ↗
    ← prev
    page 1 of 39
    next →
    $BMRN65.29-0.49%
    $GILD147.94-0.10%
    $NVO47.19-3.02%
    $ARGX1058.90+1.13%
    $SIGY0.04000.00%
    $CMPS14.64+0.21%
    $JAZZ249.29-4.20%
    $RDHL0.7390+6.64%
    $RDHL0.7390+6.64%
    $NVO47.19-3.02%
    $GILD147.94-0.10%
    $NVO47.19-3.02%